Samina Khan

Insider Reports History

Location
Plano, TX
Signature
/s/ Tracy Herson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samina Khan:

Company Role Class Num Shares Value Price $ Report Date Ownership
REATA PHARMACEUTICALS INC SVP, Chief Medical Officer Class A common stock 39,491 $6,793,455 $172.03 16 May 2023 Direct
REATA PHARMACEUTICALS INC SVP, Chief Medical Officer Employee Stock Option (right to buy) 25,000 $1,842,000 $73.68 02 Mar 2023 Direct

Insider Reports Filed by Samina Khan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123030192-khan-samina-2023-05-15 REATA PHARMACEUTICALS INC 15 May 2023 2 -$53,214 4 SVP, Chief Medical Officer 17 May 2023, 16:29
/report/000120919123017220-khan-samina-2023-03-07 REATA PHARMACEUTICALS INC 07 Mar 2023 1 -$330,585 4 SVP, Chief Medical Officer 08 Mar 2023, 15:56
/report/000120919123016306-khan-samina-2023-03-02 REATA PHARMACEUTICALS INC 02 Mar 2023 6 -$1,684,716 4 SVP, Chief Medical Officer 06 Mar 2023, 15:40
/report/000120919123001008-khan-samina-2023-01-03 REATA PHARMACEUTICALS INC 03 Jan 2023 2 $0 4 SVP, Chief Medical Officer 04 Jan 2023, 15:48
/report/000120919122007428-khan-samina-2022-02-07 REATA PHARMACEUTICALS INC 07 Feb 2022 0 $0 3 SVP, Chief Medical Officer 07 Feb 2022, 15:11